Oncotelic Therapeutics's total assets for Q2 2024 were $29.94M, a decrease of -0.13% from the previous quarter. OTLC total liabilities were $18.43M for the fiscal quarter, a -1.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.